Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
|Articles|January 11, 2022
- Vol 67 No 1
- Volume 67
- Issue 01
MiPATH Prenatal Care Recommendations: a how-to guide for maternity care professionals
Together, the American College of Obstetrics & Gynecologists (ACOG) and the University of Michigan developed MiPATH recommendations (Michigan Plan for Appropriate Tailored Healthcare) to create comprehensive, tailored prenatal care plans for patients.
Advertisement
Articles in this issue
almost 5 years ago
Designing your patient’s prenatal care “PATH”almost 5 years ago
Hysterosalpingography for boomers to zoomersalmost 5 years ago
2019 ASCCP guidelines: Pearls for practitionersalmost 5 years ago
Addressing the health care system strainalmost 5 years ago
In Memoriam: Michael J. Hennessy Sralmost 5 years ago
Menstrual cycle length affects future vascular healthalmost 5 years ago
Counseling on adverse events of intrauterine contraceptionabout 5 years ago
New risk factors for vulvovaginal candidiasis and recurrenceAdvertisement
Related to this article
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
FDA removes boxed warnings from 3 more menopausal hormone therapy products
3
Chrisandra Shufelt, MD, on cardiovascular risk assessment and menopause care
4
Matthew Nudy, MD, on estrogen and the cardiovascular system
5